0000950170-24-037389.txt : 20240327 0000950170-24-037389.hdr.sgml : 20240327 20240327173617 ACCESSION NUMBER: 0000950170-24-037389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240325 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Violette Shelia M. CENTRAL INDEX KEY: 0002016144 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38433 FILM NUMBER: 24792294 MAIL ADDRESS: STREET 1: Q32 BIO INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q32 Bio Inc. CENTRAL INDEX KEY: 0001661998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473468154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-999-0232 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Homology Medicines, Inc. DATE OF NAME CHANGE: 20151228 4 1 ownership.xml 4 X0508 4 2024-03-25 0001661998 Q32 Bio Inc. QTTB 0002016144 Violette Shelia M. Q32 BIO INC. 830 WINTER STREET WALTHAM MA 02451 false true false false Chief Scientific Officer false Stock Option (Right to Buy) 16.82 2024-03-25 4 A false 56413 0.00 A 2034-03-24 Common Stock 56413 56413 D 25% of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Eric Bell, Attorney-in-Fact 2024-03-27